Announcement of Licensing Opportunity: Antibody Stabilization
Argonne announces its intent to consider licensing certain rights to selected technologies or invention(s) pertaining to antibody stabilization. The license may be exclusive, co-exclusive or non-exclusive, and may be granted for applications in a defined field of use. Argonne solicits expression of interest from qualified organizations interested in commercializing this technology. Additional information on this technology may be found here.
Expressions of interest on this opportunity must be provided to Argonne not later than by July 15, 2009.
Interested parties may contact Dr. Yash Vaishnav. Please refer to Argonne case number ANL-IN-08-030. |
